Ke Xu

29PUBLICATIONS
34CO-AUTHORS
Haematological tumoursRadiation therapyMedical mycologyPlant cell and molecular biologyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 19, 2026
Real-world outcomes of triplet therapy with gilteritinib, azacitidine and venetoclax in FMS-like tyrosine kinase 3 (FLT3)-mutated relapsed/refractory acute myeloid leukaemia: A UK single-centre experience.

|Oct 06, 2025
The Role of Radiotherapy for Patients With Multiple Myeloma in the Modern Era: A Real World Single-Centre Experience.

Dipal Mehta, Maria Gabriel, Nathan Adu-Poku

|Oct 17, 2024
Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co-morbidities: Single-centre experience.

Dario Melotti, Samir Asher, Ethan Troy-Barnes

|Apr 05, 2024
Secondary plasma cell leukaemia (PCL) with plasmablastic morphology.

Ke Xu, Elisabeth Nacheva

|Jan 04, 2024
Chronic myeloid leukaemia (CML) presenting in B-lymphoblastic crisis: a diagnostic challenge.

Ke Xu, Elisabeth Nacheva

|Jun 01, 2023
Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience.

George Nesr, Raakhee Shah, Charalampia Kyriakou

Pageof 5

Frequent Collaborators

4 joint publications

Annabel McMillan

4 joint publications

Wei Yee Chan

3 joint publications

George Nesr

3 joint publications

Neil Rabin